Literature DB >> 25057049

A role for picomolar concentrations of pregnenolone sulfate in synaptic activity-dependent Ca2+ signaling and CREB activation.

Conor C Smith1, Stella C Martin1, Kavitha Sugunan1, Shelley J Russek1, Terrell T Gibbs1, David H Farb2.   

Abstract

Fast excitatory synaptic transmission that is contingent upon N-methyl d-aspartate receptor (NMDAR) function contributes to core information flow in the central nervous system and to the plasticity of neural circuits that underlie cognition. Hypoactivity of excitatory NMDAR-mediated neurotransmission is hypothesized to underlie the pathophysiology of schizophrenia, including the associated cognitive deficits. The neurosteroid pregnenolone (PREG) and its metabolites pregnenolone sulfate (PregS) and allopregnanolone in serum are inversely associated with cognitive improvements after oral PREG therapy, raising the possibility that brain neurosteroid levels may be modulated therapeutically. PregS is derived from PREG, the precursor of all neurosteroids, via a single sulfation step and is present at low nanomolar concentrations in the central nervous system. PregS, but not PREG, augments long-term potentiation and cognitive performance in animal models of learning and memory. In this report, we communicate the first observation that PregS, but not PREG, is a potent (EC50 ∼2 pM) enhancer of intracellular Ca(2+) that is contingent upon neuronal activity, NMDAR-mediated synaptic activity, and L-type Ca(2+) channel activity. Low picomolar PregS similarly activates cAMP response element-binding protein (CREB) phosphorylation (within 10 minutes), an essential memory molecule, via an extracellular-signal-regulated kinase/mitogen-activated protein kinase signal transduction pathway. Taken together, the results are consistent with a novel biologic role for the neurosteroid PregS that acts at picomolar concentrations to intensify the intracellular response to glutamatergic signaling at synaptic but not extrasynaptic, NMDARs by differentially augmenting CREB activation. This provides a genomic signal transduction mechanism by which PregS could participate in memory consolidation of relevance to cognitive function.
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25057049      PMCID: PMC4164982          DOI: 10.1124/mol.114.094128

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  58 in total

1.  Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway.

Authors:  R E Dolmetsch; U Pajvani; K Fife; J M Spotts; M E Greenberg
Journal:  Science       Date:  2001-10-12       Impact factor: 47.728

Review 2.  MAPK cascade signalling and synaptic plasticity.

Authors:  Gareth M Thomas; Richard L Huganir
Journal:  Nat Rev Neurosci       Date:  2004-03       Impact factor: 34.870

Review 3.  A working model of CaM kinase II activity in hippocampal long-term potentiation and memory.

Authors:  K Fukunaga; E Miyamoto
Journal:  Neurosci Res       Date:  2000-09       Impact factor: 3.304

4.  Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial.

Authors:  Michael S Ritsner; Anatoly Gibel; Tatyana Shleifer; Igor Boguslavsky; Ahmad Zayed; Rachel Maayan; Abraham Weizman; Vladimir Lerner
Journal:  J Clin Psychiatry       Date:  2010-06-15       Impact factor: 4.384

5.  A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities.

Authors:  Dan Rujescu; Andreas Bender; Martin Keck; Annette M Hartmann; Frauke Ohl; Hanna Raeder; Ina Giegling; Just Genius; Robert W McCarley; Hans-Jürgen Möller; Heinz Grunze
Journal:  Biol Psychiatry       Date:  2006-01-19       Impact factor: 13.382

6.  Distinct sites for inverse modulation of N-methyl-D-aspartate receptors by sulfated steroids.

Authors:  M Park-Chung; F S Wu; R H Purdy; A A Malayev; T T Gibbs; D H Farb
Journal:  Mol Pharmacol       Date:  1997-12       Impact factor: 4.436

Review 7.  Cognition enhancement strategies.

Authors:  James A Bibb; Mark R Mayford; Joe Z Tsien; Cristina M Alberini
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

8.  Diethylstilbestrol is a potent inhibitor of store-operated channels and capacitative Ca(2+) influx.

Authors:  Sergey I Zakharov; Tarik Smani; Yuliya Dobrydneva; Francisco Monje; Craig Fichandler; Peter F Blackmore; Victoria M Bolotina
Journal:  Mol Pharmacol       Date:  2004-09       Impact factor: 4.436

9.  Novel lipoidal derivatives of pregnenolone and dehydroepiandrosterone and absence of their sulfated counterparts in rodent brain.

Authors:  Philippe Liere; Antoine Pianos; Bernard Eychenne; Annie Cambourg; Suya Liu; William Griffiths; Michael Schumacher; Jan Sjövall; Etienne-Emile Baulieu
Journal:  J Lipid Res       Date:  2004-09-01       Impact factor: 5.922

10.  Pregnenolone sulfate induces NMDA receptor dependent release of dopamine from synaptic terminals in the striatum.

Authors:  Matthew T Whittaker; Terrell T Gibbs; David H Farb
Journal:  J Neurochem       Date:  2008-08-14       Impact factor: 5.372

View more
  3 in total

Review 1.  Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials.

Authors:  Y Iwata; S Nakajima; T Suzuki; R S E Keefe; E Plitman; J K Chung; F Caravaggio; M Mimura; A Graff-Guerrero; H Uchida
Journal:  Mol Psychiatry       Date:  2015-06-16       Impact factor: 15.992

2.  A neuroactive steroid with a therapeutically interesting constellation of actions at GABAA and NMDA receptors.

Authors:  Luke Ziolkowski; Isaac Mordukhovich; Daniel M Chen; Mariangela Chisari; Hong-Jin Shu; Peter M Lambert; Mingxing Qian; Charles F Zorumski; Douglas F Covey; Steven Mennerick
Journal:  Neuropharmacology       Date:  2020-10-25       Impact factor: 5.250

3.  Pregnenolone Inhibits Osteoclast Differentiation and Protects Against Lipopolysaccharide-Induced Inflammatory Bone Destruction and Ovariectomy-Induced Bone Loss.

Authors:  Xiaochen Sun; Chenxi Zhang; Huan Guo; Jiao Chen; Yali Tao; Fuxiao Wang; Xixi Lin; Qian Liu; Li Su; An Qin
Journal:  Front Pharmacol       Date:  2020-03-27       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.